Cargando…
Global profiling of AMG510 modified proteins identified tumor suppressor KEAP1 as an off-target
KRAS inhibitor AMG510 covalently modifies the G12C residue and inactivates the KRAS/G12C function. Because there are many reactive cysteines in the proteome, it is important to characterize AMG510 on-target modification and off-targets. Here, we presented a streamlined workflow to measure abundant A...
Autores principales: | Wang, Yini, Zhong, Bowen, Xu, Caixia, Zhan, Dongdong, Zhao, Songhao, Wu, Hongxing, Liu, Mingwei, Lan, Xiaoling, Cai, Danni, Ding, Qian, Zheng, Biao, Lan, Jiong, Lv, Qiang, Wang, Yi, Qin, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942120/ https://www.ncbi.nlm.nih.gov/pubmed/36824285 http://dx.doi.org/10.1016/j.isci.2023.106080 |
Ejemplares similares
-
Understanding the influence of AMG 510 on the structure of KRAS(G12C) empowered by molecular dynamics simulation
por: Li, Yu, et al.
Publicado: (2022) -
Mechanistic insights into the clinical Y96D mutation with acquired resistance to AMG510 in the KRAS(G12C)
por: Zhuang, Haiming, et al.
Publicado: (2022) -
KRAS(G12C)–AMG 510 interaction dynamics revealed by all-atom molecular dynamics simulations
por: Pantsar, Tatu
Publicado: (2020) -
Spotlight on Sotorasib (AMG 510) for KRAS(G12C) Positive Non-Small Cell Lung Cancer
por: Zhang, Shannon S, et al.
Publicado: (2021) -
Inhibitors Targeting CDK9 Show High Efficacy against Osimertinib and AMG510 Resistant Lung Adenocarcinoma Cells
por: Padmanabhan, Jaya, et al.
Publicado: (2021)